Long Term Outcome of Patients Receiving Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Haematologic Malignancies

被引：0
|
作者：
Tang, Si Ying [1 ,2 ]
Linn, Yeh Ching [3 ]
Tai, Bee Choo [4 ]
Poon, Michelle L. M. [1 ]
Tan, Lip Kun [1 ]
Tan, Belinda [1 ]
Lim, Yelly [1 ]
Soh, Teck Guan [1 ]
Ramos, Davanaliz Gonzales [1 ]
Hwang, William Y. K. [3 ]
Koh, Liang Piu [1 ,2 ]
机构：
[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P182
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [41] Long-Term Sustained Disease Control in Patients With Mantle Cell Lymphoma With or Without Active Disease After Treatment With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
    Vaughn, Jennifer E.
    Sorror, Mohamed L.
    Storer, Barry E.
    Chauncey, Thomas R.
    Pulsipher, Michael A.
    Maziarz, Richard T.
    Maris, Michael B.
    Hari, Parameswaran
    Laport, Ginna G.
    Franke, Georg N.
    Agura, Edward D.
    Langston, Amelia A.
    Rezvani, Andrew R.
    Storb, Rainer
    Sandmaier, Brenda M.
    Maloney, David G.
    CANCER, 2015, 121 (20) : 3709 - 3716
  • [42] Allogeneic haematopoietic stem cell transplantation after treosulfan/fludarabine conditioning in high-risk patients with haematologic malignancies
    Casper, J
    Knauf, W
    Blau, W
    Volin, L
    Ruutu, T
    Wandt, H
    Schaefer-Eckart, K
    Holowiecki, J
    Giebel, S
    Aschan, J
    Zander, A
    Kroeger, N
    Freund, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S103 - S104
  • [43] Allogeneic hematopoietic cell transplantation (alloHCT) in diffuse large B-cell lymphoma (DLBCL) after nonmyeloablative (NMA) or reduced-intensity (RIC) conditioning: Long-term outcome in 116 patients
    Poon, L. M.
    Saliba, Rima
    Rondon, Gabriela
    Okoroji, Grace-Julia
    Oki, Yasuhiro
    Champlin, Richard E.
    Hosing, Chitra
    Young, Ken H.
    Turturro, Francesco
    Khouri, Issa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients
    Stadler, Michael
    Dammann, Elke
    Buchholz, Stefanie
    Hertenstein, Bernd
    Krauter, Juergen
    Eder, Matthias
    Ganser, Arnold
    BLOOD, 2009, 114 (22) : 1315 - 1316
  • [45] Impact of ATG use on the outcome of patients with hematological malignancies undergoing reduced-intensity conditioning for allogeneic hematopoietic cell transplantation
    Greinix, H.
    Beohou, E.
    van der Werf, S.
    Niederwieser, D.
    Blaise, D.
    Dreger, P.
    Arnold, R.
    Meijer, E.
    Sengeloev, H.
    Cornelissen, J.
    Hallek, M.
    Socie, G.
    Chevallier, P.
    Ganser, A.
    Milpied, N.
    Maertens, J.
    Petersen, E.
    Afanasyev, B.
    Ehninger, G.
    Fegueux, N.
    Jindra, P.
    Kroeger, N.
    Montoto, S.
    Nagler, A.
    Duarte, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S61 - S61
  • [46] Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation
    Tabbara, IA
    Ingram, RA
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 559 - 566
  • [47] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Schneidawind, Dominik
    Federmann, Birgit
    Buechele, Corina
    Helwig, Andrea
    Schmohl, Joerg
    Vogel, Wichard
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 115 - 124
  • [48] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Dominik Schneidawind
    Birgit Federmann
    Corina Buechele
    Andrea Helwig
    Jörg Schmohl
    Wichard Vogel
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Annals of Hematology, 2016, 95 : 115 - 124
  • [49] Longer follow up of patients (PTS) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)
    Sorror, M. L.
    Storer, B.
    Sandmaier, B. M.
    Maris, M. B.
    Shizuru, J.
    Niederwieser, D.
    Agura, E.
    Chauncey, T.
    Maziarz, R.
    Pulsipher, M.
    McSweeney, P.
    Wade, J.
    Bruno, B.
    Langston, A.
    Blume, K.
    Storb, R.
    Maloney, D. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 133 - 134
  • [50] Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
    Baron, F
    Maris, MB
    Sandmaier, BM
    Storer, BE
    Sorror, M
    Diaconescu, R
    Woolfrey, AE
    Chauncey, TR
    Flowers, MED
    Mielcarck, M
    Maloney, DG
    Storb, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1993 - 2003
12345